ials, procedural failures ranged from 0.5% to 2% and
were almost all secondary to the inability to advance
the device through inadequate iliac arterial systems.80,89,90 There has been an effort recently to
decrease the size of the sheaths and to improve the
trackability of TEVAR delivery systems. Nonetheless, a
study of a lower proÔ¨Åle device (sheath sizes 16F-20F) still
